Apellis Pharmaceuticals, Inc. · NASDAQ:APLS

Rtw Investments, LP reported a 6.10% stake in Apellis Pharmaceuticals, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Feb 17, 2026

Rtw Investments, LP reported a 6.10% stake in Apellis Pharmaceuticals, Inc., 7,666,764 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).

Stake
6.10%
Shares
7,666,764
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
RTW Investments, LP6.10%7,666,764
Roderick Wong6.10%7,666,764

Source

View original at SEC

Related